San Diego, CA
Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.
capstantx.comThese are collections Capstan Therapeutics is a part of. Click on the collection name to view similar companies.
Series B
$175,000,000
Series A
$102,000,000
Seed
$63,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Capstan Therapeutics.